Dennis Wolf Selected Research

Hypercholesterolemia

11/2019	Glucose lowering by SGLT2-inhibitor empagliflozin accelerates atherosclerosis regression in hyperglycemic STZ-diabetic mice.
3/2016	Atheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dennis Wolf Research Topics

Disease

33	Atherosclerosis 01/2023 - 04/2010
29	Inflammation (Inflammations) 12/2023 - 04/2010
15	Atherosclerotic Plaque (Atheroma) 01/2024 - 07/2010
12	Obesity 04/2024 - 01/2012
5	Heart Failure 04/2024 - 01/2023
5	Body Weight (Weight, Body) 01/2024 - 04/2017
5	Hemorrhage 01/2023 - 10/2019
5	Stroke (Strokes) 01/2023 - 01/2021
5	Acute Coronary Syndrome 01/2022 - 05/2010
5	Weight Gain 10/2021 - 01/2012
5	Insulin Resistance 10/2018 - 01/2012
4	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 04/2010
4	Myocardial Infarction 11/2022 - 01/2016
4	Sepsis (Septicemia) 01/2021 - 10/2014
4	Thrombosis (Thrombus) 12/2019 - 11/2011
3	Type 2 Diabetes Mellitus (MODY) 01/2024 - 01/2019
3	Weight Loss (Weight Reduction) 01/2024 - 01/2023
3	Cardiomyopathies (Cardiomyopathy) 11/2023 - 01/2019
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 04/2010
3	Coronary Disease (Coronary Heart Disease) 03/2020 - 07/2010
2	Fibrosis (Cirrhosis) 11/2022 - 01/2021
2	Neoplasms (Cancer) 10/2022 - 01/2018
2	Emergence Delirium 07/2022 - 12/2021
2	Coronary Artery Disease (Coronary Atherosclerosis) 07/2022 - 01/2022
2	Infarction (Infarctions) 01/2022 - 12/2019
2	Myocarditis (Carditis) 12/2021 - 01/2021
2	Hypercholesterolemia 11/2019 - 03/2016
2	Intracranial Aneurysm (Cerebral Aneurysm) 11/2017 - 01/2017
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 11/2017 - 10/2017
2	Metabolic Diseases (Metabolic Disease) 01/2017 - 01/2012
2	Peritonitis 01/2016 - 04/2011
2	Asthma (Bronchial Asthma) 10/2014 - 09/2011
1	Delirium 01/2023

Drug/Important Bio-Agent (IBA)

12	CholesterolIBA 01/2023 - 07/2010
11	CytokinesIBA 12/2022 - 04/2010
10	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2017
10	ApolipoproteinsIBA 01/2023 - 04/2017
9	RNA (Ribonucleic Acid)IBA 01/2023 - 07/2010
9	Apolipoproteins E (ApoE)IBA 12/2022 - 03/2016
9	Apolipoproteins B (ApoB)IBA 01/2022 - 04/2017
8	Peptides (Polypeptides)IBA 01/2022 - 11/2011
7	CD40 Ligand (CD40L)IBA 10/2019 - 04/2010
6	LipidsIBA 11/2022 - 01/2018
6	LigandsIBA 01/2022 - 09/2010
5	semaglutideIBA 04/2024 - 01/2023
5	C-Reactive ProteinIBA 04/2024 - 03/2020
5	Insulin (Novolin)FDA Link 01/2023 - 01/2012
5	oxidized low density lipoproteinIBA 01/2022 - 04/2017
5	LDL Receptors (LDL Receptor)IBA 01/2022 - 07/2010
4	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 06/2014
4	Adenosine Triphosphate (ATP)IBA 01/2022 - 01/2016
4	Purinergic Receptors (Receptors, Purine)IBA 01/2022 - 10/2014
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 05/2010
4	AntigensIBA 12/2021 - 10/2015
4	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2021 - 05/2010
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022 - 01/2021
3	CC ChemokinesIBA 01/2022 - 10/2014
3	VaccinesIBA 12/2021 - 10/2015
3	TNF Receptor-Associated Factor 5IBA 10/2021 - 09/2010
3	LDL CholesterolIBA 01/2021 - 04/2017
3	ChemokinesIBA 01/2018 - 10/2014
2	Protein CIBA 12/2023 - 01/2013
2	Particulate MatterIBA 11/2023 - 01/2016
2	Serotonin (5 Hydroxytryptamine)IBA 01/2023 - 12/2019
2	Lipoproteins (Lipoprotein)IBA 12/2022 - 12/2020
2	Interleukin-10 (Interleukin 10)IBA 12/2022 - 04/2017
2	Green Fluorescent ProteinsIBA 12/2022 - 12/2019
2	Adiponectin ReceptorsIBA 05/2022 - 01/2019
2	AntibodiesIBA 01/2022 - 01/2012
2	Prasugrel Hydrochloride FDA Link 01/2022 - 12/2021
2	Purinergic P2 Receptors (ADP Receptor)IBA 01/2022 - 10/2018
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2012
2	InflammasomesIBA 01/2022 - 06/2017
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 04/2010
2	Freund's AdjuvantIBA 12/2021 - 04/2017
2	AutoantibodiesIBA 12/2021 - 01/2021
2	Factor V (Coagulation Factor V)IBA 10/2021 - 01/2019
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2021 - 03/2020
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 11/2018
2	CollagenIBA 11/2019 - 10/2019
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 10/2018 - 10/2014
2	incomplete Freund's adjuvantIBA 01/2018 - 04/2017
2	AdipokinesIBA 01/2018 - 01/2012
2	IntegrinsIBA 01/2018 - 01/2017
2	Oxygen (Dioxygen)IBA 11/2017 - 01/2017
2	fostamatinibIBA 03/2016 - 09/2011
2	Messenger RNA (mRNA)IBA 09/2010 - 05/2010
1	Glucagon-Like Peptide-1 ReceptorIBA 04/2024
1	Chemokine ReceptorsIBA 01/2024
1	Complement C3 (C3 Complement)IBA 12/2023
1	Mannose-Binding Protein-Associated Serine Proteases (Mannose-Binding Protein-Associated Serine Protease)IBA 12/2023
1	Kallikreins (Kallikrein)IBA 12/2023
1	ProteomeIBA 12/2023
1	Complement Factor D (Factor D)IBA 12/2023
1	Factor IX (Coagulation Factor IX)FDA LinkGeneric 12/2023

Therapy/Procedure

9	Therapeutics 01/2024 - 10/2015
4	Transcatheter Aortic Valve Replacement 01/2023 - 11/2020
2	Subcutaneous Injections 12/2021 - 01/2017
2	Lasers (Laser) 11/2017 - 01/2017
1	Artificial Respiration (Mechanical Ventilation) 01/2023